Share this Job

Assistant Scientist 1

Req ID:  41322

Tranent, ELN, GB, EH33 2NE

For nearly 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.




At our world class facility in Elphinstone, Tranent (close to Edinburgh), our Department of Bioanalysis and Immunology currently has an exciting career opportunity for an Assistant Scientist.  You will be fully trained in all aspects of job, including sample processing, set-up/operation of analytical systems (primarily HPLC with mass spectrometric detection) and data review and processing (using Watson LIMS), so that you can play a full role in the conduct of bioanalytical studies.


Duties and responsibilities include:-

  • Wet lab work to support the validation and application of analytical methods to measure the levels of drugs and metabolites in biological fluids
  • Use and maintenance of HPLC and Mass Spectrometry equipment
  • Reporting of varied data sets to supervisors and clients


Applicants should have:-

  • An Honours degree (or equivalent) in Chemistry or a related discipline.
  • A working knowledge of sample preparation and chromatographic techniques
  • Good problem solving skills and be able to work to tight deadlines and record data accurately
  • The ability to communicate effectively.


Salary banding for this position is £20,841 - £22,407.  Successful candidates will be appointed to the bottom of the pay band if they have no relevant experience.

In exceptional circumstances where the candidate has relevant equivalent experience, this will be taken into consideration.


The closing date for this position is 22 January 2019



About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges.  Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.

For more information, please visit